Relaxo Q2 FY27: PAT +2% YoY to ₹36.95 Cr, standalone, as margins compress missing OPM goal
PAT +2.18% YoY · revenue +11.63% · margins compressing · miss vs street
₹701.62 Cr
+11.63% YoY
₹36.95 Cr
+2.18% YoY
5.17%
-0.5pp YoY
₹1.48
Relaxo's standalone PAT rose just 2.2% YoY to ₹36.95 Cr even as revenue from operations grew a healthier 11.6% YoY to ₹701.62 Cr — profit growth trailing topline growth by a wide margin, the hallmark of margin compression rather than demand weakness. Operating margin (EBITDA excl. other income/revenue) fell to 12.15% from 12.91% a year ago, and net margin slipped to 5.27% from 5.64%. Sequentially, revenue was flat-to-down 0.5% from Q1 FY27's ₹705.05 Cr, while PAT fell 32.7% QoQ and OPM dropped from 15.35% — a seasonal step-down (Q1 is the peak summer season for footwear) rather than a trend reversal, and QoQ figures should not be read as a deterioration signal on their own.
Q2 FY-2027 vs prior quarters
The compression is broad-based on costs: material costs rose 13.1% YoY, employee expense 15.3%, other expenses 14.1% and finance costs 18.6% — all outpacing the 11.6% revenue growth. The finance-cost and depreciation increases trace to EBO expansion (right-of-use assets up to ₹411.92 Cr from ₹390 Cr at FY26-end), a strategic driver management itself flagged on the Q4 FY26 call. That call had targeted OPM improvement of over 100bps versus FY26's 13.8% average; instead, Q2 FY27 OPM of 12.15% sits below both the FY26 base and the prior-year quarter, so management's own margin guidance has been missed this quarter, even as the revenue-growth leg of that guidance (supported by price hikes) came through.
The stock went into the print at ₹294.55, down 1.9% over the past month of trading.
What the summary numbers don't show
H1 FY27: revenue ₹1,406.67 Cr (+9.6% YoY), PAT ₹91.89 Cr (+8.0% YoY) — basic EPS ₹1.48 for the quarter vs ₹1.46 YoY and ₹2.21 QoQ.
Management expressed confidence in sustaining Q4 performance in the near term, with an intent to improve operating margins by over 1% compared to FY26's 13.8%. While acknowledging geopolitical uncertainties and potential inflationary pressures, they foresee revenue growth supported by continued price increases and volu
— This quarter: missed
Our pre-result preview had flagged revenue of ₹700–750 Cr, EBITDA growth of 8–9% and net-margin resilience as the gauges to watch; revenue landed at the low end (₹701.62 Cr, in line), but EBITDA grew only ~4.6% YoY (₹97.74 Cr vs ₹93.42 Cr) and net margin compressed rather than held — a miss on the two profitability watch items despite the in-line topline. No fresh brokerage consensus for this specific print could be sourced (Q2 FY27 coverage had not yet updated), so this grading rests on our own preview and the company's own guidance. During the quarter the company also signed renewable-energy agreements and announced (post-quarter, Oct 23) a 26% stake in Clean Max MUOI for captive power — a cost initiative whose benefit isn't yet visible in Q2 margins — while ICRA reaffirmed its AA/Stable and A1+ ratings, indicating no credit-quality concern despite the operating-margin miss.
W1
OPM recovery toward management's guided >14.8% (FY26's 13.8% +100bps) — Q2 FY27 ran at 12.15%, ~265bps short.
W2
EBO expansion payoff: right-of-use assets at ₹411.92 Cr are adding lease/depreciation/employee costs now — watch whether premiumization/ASP gains offset this in H2.
W3
Capex pacing versus the ₹180–200 Cr FY27 guidance — H1 capex (PPE + CWIP) was ₹66.50 Cr, implying a H2 ramp is needed to hit the full-year range.
No subsidiary/associate/JV exists (note 5) — standalone is the only statement, consolidated is not applicable; limited-review unaudited figures; no exceptional items; minor ESOP grant (5,03,500 options) during the quarter under Ind AS 102.